These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12908490)

  • 41. [Hypertension 2007-2008].
    Chatzikyrkou C; Menne J; Haller H
    Med Klin (Munich); 2009 Aug; 104(8):614-21. PubMed ID: 19701732
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?
    Bauer JH; Reams GP
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of health costs associated with treatment of hypertension with a calcium channel blocker and angiotensin-converting enzyme inhibitor in the United States and Japan.
    Sakamaki Y; Sasamura H; Ikeda S; Ikegami N; Saruta T
    Hypertens Res; 2006 May; 29(5):333-8. PubMed ID: 16832153
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
    Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
    Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Managing hypertension using combination therapy.
    Frank J
    Am Fam Physician; 2008 May; 77(9):1279-86. PubMed ID: 18540493
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Medical treatment of small abdominal aortic aneurysms].
    Høgh AL; Sandermann J; Lindholt JS
    Ugeskr Laeger; 2008 Jun; 170(23):2003-5. PubMed ID: 18534161
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Atrial remodeling and anti-remodeling therapy in atrial fibrillation].
    Neumann T; Hölschermann H
    Dtsch Med Wochenschr; 2006 Apr; 131(16):884-7. PubMed ID: 16625482
    [No Abstract]   [Full Text] [Related]  

  • 48. Oral adverse effects of drugs: Taste disorders.
    Rademacher WMH; Aziz Y; Hielema A; Cheung KC; de Lange J; Vissink A; Rozema FR
    Oral Dis; 2020 Jan; 26(1):213-223. PubMed ID: 31532870
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists.
    Quan A
    Early Hum Dev; 2006 Jan; 82(1):23-8. PubMed ID: 16427219
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Drug dependent ageusia].
    Poeck K
    Dtsch Med Wochenschr; 1971 Sep; 96(36):1449. PubMed ID: 5565980
    [No Abstract]   [Full Text] [Related]  

  • 51. A cohort study of antihypertensive medication use and breast cancer among Danish women.
    Fryzek JP; Poulsen AH; Lipworth L; Pedersen L; Nørgaard M; McLaughlin JK; Friis S
    Breast Cancer Res Treat; 2006 Jun; 97(3):231-6. PubMed ID: 16791484
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Doc, I can't taste my food!
    Madnani NA; Khan KJ
    Indian J Dermatol Venereol Leprol; 2010; 76(3):296-7. PubMed ID: 20445311
    [No Abstract]   [Full Text] [Related]  

  • 53. The choice of antihypertensive therapy in patients with the metabolic syndrome--time to change recommendations?
    Hilgers KF; Mann JF
    Nephrol Dial Transplant; 2008 Nov; 23(11):3389-91. PubMed ID: 18687734
    [No Abstract]   [Full Text] [Related]  

  • 54. Antihypertensive drugs and fibrinolytic function.
    Fogari R; Zoppi A
    Am J Hypertens; 2006 Dec; 19(12):1293-9. PubMed ID: 17161777
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Two amlodipine/ARB combinations for hypertension.
    Med Lett Drugs Ther; 2007 Dec; 49(1276):101-2. PubMed ID: 18084152
    [No Abstract]   [Full Text] [Related]  

  • 56. Recent advances in cardiorespiratory medicine: management of pulmonary embolism and prevention of venous thromboembolism, recent treatment strategies in childhood asthma, and dermatological adverse reactions to cardiovascular drugs.
    Finucane KA; Archer CB
    Clin Exp Dermatol; 2008 May; 33(3):356-60. PubMed ID: 18312463
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Drug-related taste disturbances.
    Tomita H; Yoshikawa T
    Acta Otolaryngol Suppl; 2002; (546):116-21. PubMed ID: 12132608
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Non-antiarrhythmic drugs in atrial fibrillation: a review of non-antiarrhythmic agents in prevention of atrial fibrillation.
    Lally JA; Gnall EM; Seltzer J; Kowey PR
    J Cardiovasc Electrophysiol; 2007 Nov; 18(11):1222-8. PubMed ID: 17553070
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Angiotensin receptor blockers and secondary stroke prevention: the MOSES study.
    Dowlatshahi D; Hill MD
    Expert Rev Cardiovasc Ther; 2009 May; 7(5):459-64. PubMed ID: 19419253
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Hypertension therapy in practice test. Calcium antagonist receives good marks].
    Keck M; Sauerbrey-Wullkopf N; Regourd E; Clemens A
    MMW Fortschr Med; 2005 Jan; 147(1-2):51. PubMed ID: 15704573
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.